Velano Vascular has closed a $25m round following an extension that added to $10m provided by investors including Intermountain Healthcare in May.
US-based blood testing device producer Velano Vascular completed a $25m funding round featuring care provider Intermountain Healthcare on Tuesday after securing a $15m extension.
Velano did not name the latest participants, noting only that the round’s new and existing investors included hospitals and multinational healthcare companies, venture capital firms and executives. It received an initial $10m from Intermountain, Kapor Capital and assorted indivuduals in May this year.
Founded in 2011, Velano produces a medical device, Pivo, that facilitates the…
